ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $701,065 | +41.3% | 1,426 | +12.0% | 0.04% | +48.1% |
| Q2 2023 | $496,127 | +8.2% | 1,273 | +3.4% | 0.03% | 0.0% |
| Q1 2023 | $458,646 | -10.8% | 1,231 | -9.4% | 0.03% | -18.2% |
| Q4 2022 | $514,451 | +10.4% | 1,358 | +2.8% | 0.03% | 0.0% |
| Q3 2022 | $466,000 | -1.3% | 1,321 | +6.0% | 0.03% | +3.1% |
| Q2 2022 | $472,000 | +92.7% | 1,246 | +60.4% | 0.03% | +128.6% |
| Q1 2022 | $245,000 | -7.5% | 777 | +2.8% | 0.01% | -6.7% |
| Q4 2021 | $265,000 | +31.2% | 756 | +13.2% | 0.02% | +25.0% |
| Q3 2021 | $202,000 | -14.8% | 668 | -22.2% | 0.01% | -33.3% |
| Q1 2021 | $237,000 | +12.9% | 859 | +20.5% | 0.02% | +28.6% |
| Q4 2020 | $210,000 | – | 713 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |